Biontech SE
BNTX98.080USD
0.000
收盤 09/26, 16:00（美東）報價延遲15分鐘
23.58B總市值
虧損本益比TTM
關於 公司
公司簡介
公司代碼BNTX
公司名稱Biontech SE
上市日期Oct 10, 2019
CEOProf. Ugur Sahin, M.D.
員工數量6772
證券類型Depository Receipt
年結日Oct 10
公司地址An der Goldgrube 12
城市MAINZ
上市交易所NASDAQ Global Select Consolidated
國家Germany
郵編55131
電話4949613190840
網址https://www.biontech.com/
公司代碼BNTX
上市日期Oct 10, 2019
CEOProf. Ugur Sahin, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Sierk Poetting, Ph.D.
Dr. Sierk Poetting, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
767.54K
+1.69%
Mr. Ryan Richardson
Mr. Ryan Richardson
Chief Strategy Officer, Member of the Management Board
Chief Strategy Officer, Member of the Management Board
26.55K
+80.66%
Dr. Ulrich Wandschneider, Ph.D.
Dr. Ulrich Wandschneider, Ph.D.
Independent Deputy Chairman of the Supervisory Board
Independent Deputy Chairman of the Supervisory Board
1.48K
--
Mr. James Ryan
Mr. James Ryan
Member of the Management Board, Chief Legal Officer
Member of the Management Board, Chief Legal Officer
790.00
--
Prof. Rudolf Staudigl, Ph.D.
Prof. Rudolf Staudigl, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
400.00
--
Prof. Anja Morawietz, Ph.D.
Prof. Anja Morawietz, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
240.00
--
Mr. Ramon Zapata Gomez
Mr. Ramon Zapata Gomez
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Helmut Jeggle
Mr. Helmut Jeggle
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Dr. Oezlem Tuereci, M.D.
Dr. Oezlem Tuereci, M.D.
Chief Medical Office, Member of the Management Board
Chief Medical Office, Member of the Management Board
--
--
Ms. Baroness Nicola Blackwood
Ms. Baroness Nicola Blackwood
Member of the Supervisory Board
Member of the Supervisory Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Sierk Poetting, Ph.D.
Dr. Sierk Poetting, Ph.D.
Chief Operating Officer, Member of the Management Board
Chief Operating Officer, Member of the Management Board
767.54K
+1.69%
Mr. Ryan Richardson
Mr. Ryan Richardson
Chief Strategy Officer, Member of the Management Board
Chief Strategy Officer, Member of the Management Board
26.55K
+80.66%
Dr. Ulrich Wandschneider, Ph.D.
Dr. Ulrich Wandschneider, Ph.D.
Independent Deputy Chairman of the Supervisory Board
Independent Deputy Chairman of the Supervisory Board
1.48K
--
Mr. James Ryan
Mr. James Ryan
Member of the Management Board, Chief Legal Officer
Member of the Management Board, Chief Legal Officer
790.00
--
Prof. Rudolf Staudigl, Ph.D.
Prof. Rudolf Staudigl, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
400.00
--
Prof. Anja Morawietz, Ph.D.
Prof. Anja Morawietz, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
240.00
--
收入明細
單位: USD更新時間: 3月12日 週三
單位: USD更新時間: 3月12日 週三
FY2019
FY2018
FY2017
業務USD
名稱
營收
佔比
Collaboration Revenue
84.43M
77.75%
Revenues from Other Sales Transactions
24.16M
22.25%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Collaboration Revenue
84.43M
77.75%
Revenues from Other Sales Transactions
24.16M
22.25%
股東統計
更新時間: 8月17日 週日
更新時間: 8月17日 週日
持股股東
股東類型
持股股東
持股股東
佔比
AT Impf GmbH
42.37%
Medine GmbH
16.69%
Baillie Gifford & Co.
3.34%
Fidelity Management & Research Company LLC
2.90%
Flossbach von Storch AG
1.76%
其他
32.93%
持股股東
持股股東
佔比
AT Impf GmbH
42.37%
Medine GmbH
16.69%
Baillie Gifford & Co.
3.34%
Fidelity Management & Research Company LLC
2.90%
Flossbach von Storch AG
1.76%
其他
32.93%
股東類型
持股股東
佔比
Corporation
60.58%
Investment Advisor
16.91%
Investment Advisor/Hedge Fund
3.59%
Individual Investor
2.11%
Research Firm
1.00%
Hedge Fund
0.83%
Sovereign Wealth Fund
0.63%
Bank and Trust
0.22%
Pension Fund
0.19%
其他
13.94%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
815
205.26M
85.38%
-4.32M
2025Q1
851
205.71M
85.57%
-4.55M
2024Q4
869
205.33M
85.56%
+3.19M
2024Q3
843
197.46M
82.52%
-2.61M
2024Q2
819
194.42M
81.78%
-7.50M
2024Q1
835
193.57M
81.42%
-10.02M
2023Q4
897
193.24M
81.29%
-7.90M
2023Q3
920
192.71M
79.62%
-7.47M
2023Q2
940
195.49M
80.61%
-8.54M
2023Q1
953
197.88M
81.52%
-6.52M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
AT Impf GmbH
101.85M
42.37%
-636.54K
-0.62%
Dec 31, 2024
Medine GmbH
40.13M
16.69%
-304.48K
-0.75%
Mar 31, 2025
Baillie Gifford & Co.
8.16M
3.39%
-60.90K
-0.74%
Mar 31, 2025
Fidelity Management & Research Company LLC
5.95M
2.48%
-495.85K
-7.69%
Mar 31, 2025
Flossbach von Storch AG
4.26M
1.77%
-147.21K
-3.34%
Mar 31, 2025
PRIMECAP Management Company
4.05M
1.68%
-249.39K
-5.81%
Mar 31, 2025
Pfizer Inc
3.66M
1.52%
--
--
Mar 31, 2025
Sahin (Ugur MD)
2.05M
0.85%
-724.50K
-26.11%
Mar 31, 2025
Temasek Holdings Pte. Ltd.
1.81M
0.75%
--
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 9月6日 週六
更新時間: 9月6日 週六
機構名稱
佔比
iShares Genomics Immunology and Healthcare ETF
3.71%
Global X Genomics & Biotechnology ETF
3.6%
Langar Global HealthTech ETF
3.46%
First Trust NYSE Arca Biotechnology Index Fund
2.97%
Franklin Genomic Advancements ETF
2.68%
VanEck Biotech ETF
2.65%
WisdomTree BioRevolution Fund
1.8%
Virtus LifeSci Biotech Products ETF
1.74%
iShares Biotechnology ETF
1.44%
ProShares Ultra Nasdaq Biotechnology
1.15%
查看更多
iShares Genomics Immunology and Healthcare ETF
佔比3.71%
Global X Genomics & Biotechnology ETF
佔比3.6%
Langar Global HealthTech ETF
佔比3.46%
First Trust NYSE Arca Biotechnology Index Fund
佔比2.97%
Franklin Genomic Advancements ETF
佔比2.68%
VanEck Biotech ETF
佔比2.65%
WisdomTree BioRevolution Fund
佔比1.8%
Virtus LifeSci Biotech Products ETF
佔比1.74%
iShares Biotechnology ETF
佔比1.44%
ProShares Ultra Nasdaq Biotechnology
佔比1.15%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
